Theoretical Analysis
Thymosin Alpha 1 (Tα1)
Chemical Formula: C129H215N33O55
Molecular Mass: 3108.3
Synonyms: Thymosin Alpha 1, Tα1
CAS Number: 62304-98-7
Vial Size: 3ml
Vial Contents: Lyophilized Powder (>99% purity)
Overview
Thymosin Alpha 1 (Tα1) is a synthetic peptide derived from a protein called prothymosin alpha. It is known for its immune-modulating properties and is studied for its potential to enhance immune function, combat infections, and regulate immune responses. Tα1 has been used clinically in various countries for its immunotherapeutic effects, particularly in the treatment of chronic infections, cancer, and autoimmune diseases.
Key Features and Benefits:
- Immune Modulation: Thymosin Alpha 1 enhances the body’s immune response by stimulating the activity of T-cells and other immune cells.
- Antiviral Properties: It has demonstrated efficacy in combating viral infections, making it a valuable candidate for treating diseases like hepatitis and HIV.
- Cancer Therapy: Tα1 is studied for its potential to improve the immune system’s ability to target and destroy cancer cells.
- Autoimmune Disease Management: It helps in regulating immune responses, potentially reducing the severity of autoimmune diseases.
Research Uses and Mechanism of Action Studies
Thymosin Alpha 1’s primary applications and mechanisms of action include:
-
Immune System Enhancement:
- Tα1 stimulates the production and activity of various immune cells, including T-cells, dendritic cells, and natural killer (NK) cells.
- Research focuses on its ability to enhance the immune response in immunocompromised patients and those with chronic infections.
-
Antiviral Activity:
- Thymosin Alpha 1 has been shown to inhibit viral replication and enhance the clearance of viral infections.
- Studies investigate its use in treating chronic viral infections such as hepatitis B and C, as well as its potential in managing HIV/AIDS.
-
Cancer Immunotherapy:
- Tα1 is explored for its ability to boost the immune system’s response to cancer, potentially improving the efficacy of existing cancer treatments.
- Research includes its use in combination with other therapies, such as chemotherapy and immune checkpoint inhibitors, to enhance their effectiveness.
-
Autoimmune Disease Regulation:
- Thymosin Alpha 1 modulates the immune response, helping to balance overactive immune reactions that occur in autoimmune diseases.
- Studies focus on its potential to reduce inflammation and tissue damage in conditions like multiple sclerosis, rheumatoid arthritis, and lupus.
Product Usage
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.
This designation restricts the use of Thymosin Alpha 1 strictly to in vitro testing and laboratory experimentation. All product information available on this website is for educational purposes only.
Important Usage Information:
- Bodily Introduction: Any form of bodily introduction into humans or animals is strictly forbidden by law.
- Handling: This product should only be handled by licensed, qualified professionals.
- Misuse: This product is not a drug, food, or cosmetic and must not be misbranded, misused, or mislabeled as such.
Legal Disclaimer: The information provided here is intended solely for research and educational purposes and should not be used for any unauthorized applications.
